Duarte; City of Hope
BMT CTN 0402: A Phase III Randomized, Multicenter Trial Comparing Sirolimus/Tacrolimus with Tacrolimus/Methotrexate as Graft-Versus-Host-Disease (GVHD)Prophylaxis After HLA-Matched, Related Peripheral Blood Stem Cell Transplantation
Duarte; City of Hope
A Randomized, Double-Blind, Placebo-Controlled Study To Assess The Efficacy and Safety of Prophylactic Use of Maribavir for the Prevention of Cytomegalovirus Disease in Recipients of Allogeneic Stem Cell Transplants
Duarte; City of Hope
Defibrotide for the Treatment of Severe Hepatic Veno-Occlusive Disease in Hematopoietic Stem Cell Transplant Patients: A Historically-Controlled, Multi-Center Phase III Study to Determine Safety and Efficacy
Duarte; City of Hope
A Phase II, Multicenter, Prospective, Observational, Open-Label Study to Evaluate the Safety and Efficacy of AMD3100 (240ug/kg) Added to a G-CSF Mobilization Regimen in Poor Mobilizing Adult Patients Who Have Previously Failed Stem Cell Collections or Collection Attempts
Duarte; City of Hope
A Phase 2 Clinical Trial to Evaluate the Safety, Immunogenecity and Clinical Benefit of a CMV Immunotherapeutic Vaccine in Donors and CMV-Seropositive Recipients Undergoing Allogeneic, Matched, Related Hematpoietic Cell Transplant (HCT)
Duarte; City of Hope
A Phase II Study of Sirolimus, Tacrolimus and Thymoglobulin, as Graft-versus-Host Prophylaxis in Patients Undergoing Unrelated Donor Hematopoietic Cell Transplantation
